HU0800407D0 - Thieno [2,3-b] pyridine compounds with mglur activity - Google Patents
Thieno [2,3-b] pyridine compounds with mglur activityInfo
- Publication number
- HU0800407D0 HU0800407D0 HU0800407A HUP0800407A HU0800407D0 HU 0800407 D0 HU0800407 D0 HU 0800407D0 HU 0800407 A HU0800407 A HU 0800407A HU P0800407 A HUP0800407 A HU P0800407A HU 0800407 D0 HU0800407 D0 HU 0800407D0
- Authority
- HU
- Hungary
- Prior art keywords
- thieno
- pyridine compounds
- mglur activity
- mglur
- activity
- Prior art date
Links
- SMZMHUCIDGHERP-UHFFFAOYSA-N thieno[2,3-b]pyridine Chemical class C1=CN=C2SC=CC2=C1 SMZMHUCIDGHERP-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Immunology (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Addiction (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU0800407A HUP0800407A2 (en) | 2008-06-30 | 2008-06-30 | Thieno [2,3-b] pyridine compounds as metalotropic glutamate receptor (mglur) ligands |
PCT/HU2009/000052 WO2010001185A1 (en) | 2008-06-30 | 2009-06-25 | Thieno [2,3-b] pyridine compounds with mglur activity |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU0800407A HUP0800407A2 (en) | 2008-06-30 | 2008-06-30 | Thieno [2,3-b] pyridine compounds as metalotropic glutamate receptor (mglur) ligands |
Publications (2)
Publication Number | Publication Date |
---|---|
HU0800407D0 true HU0800407D0 (en) | 2008-08-28 |
HUP0800407A2 HUP0800407A2 (en) | 2010-03-01 |
Family
ID=89988365
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0800407A HUP0800407A2 (en) | 2008-06-30 | 2008-06-30 | Thieno [2,3-b] pyridine compounds as metalotropic glutamate receptor (mglur) ligands |
Country Status (2)
Country | Link |
---|---|
HU (1) | HUP0800407A2 (hu) |
WO (1) | WO2010001185A1 (hu) |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009520016A (ja) * | 2005-12-20 | 2009-05-21 | リヒター ゲデオン ニュルト | 新規な化合物 |
-
2008
- 2008-06-30 HU HU0800407A patent/HUP0800407A2/hu unknown
-
2009
- 2009-06-25 WO PCT/HU2009/000052 patent/WO2010001185A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2010001185A1 (en) | 2010-01-07 |
HUP0800407A2 (en) | 2010-03-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA201108885B (en) | 3-([1,2,3]triazole-4yl)-pyrrolo[2,3-b]pyridine derivates | |
EP2265616B8 (en) | Furo-and thieno[3,2-c]pyridines | |
BRPI0919948A2 (pt) | Pirido[4,3-b]indois contendo porções rígidas | |
HK1179617A1 (en) | 2,5,6,7-tetrahydro-[1,4]oxazepin-3-ylamine or 2,3,6,7-tetrahydro- [1,4]oxazepin-5-ylamine compounds 2567--[14]-3- 2367--[14]-5- | |
ZA201106599B (en) | Pyrrolo [2,3-b] pyridine derivatives for the inhibition of raf kinases | |
AP2939A (en) | Thieno [2,3-B] pyridine derivatives as viral replication inhibitors | |
ZA201004524B (en) | Pyrido[2,3-b]pyrazine-8-substituted compounds and their use | |
IL225622A0 (en) | Furo[3, 2-di]pyrimidine compounds | |
IL207845A0 (en) | Pyrazole [3,4-b] pyridine raf inhibitors | |
BRPI0722088A2 (pt) | derivados de pirrolo[2,3-b]piridina como moduladores de cinase | |
SI2013208T1 (sl) | Piridin(3,4-b)pirazinoni | |
ZA201206630B (en) | Hetaryl-[1,8]naphthyridine derivatives | |
ZA201208616B (en) | Substituted 2,3-dihydroimidazo[1,2-c]quinazoline-containing combinations | |
EP2257169A4 (en) | TETRAHYDROTHIENPYRIDINE | |
IL232717A0 (en) | 3-cyanoaryl-h1-pyrrolo[b-3,2]pyridine derivatives | |
ZA201005959B (en) | 4-(pyrrolo[2,3-c]pyridine-3-yl)-pyrimidine-2-amine derivatives | |
EP2142542A4 (en) | NEW IMIDAZO [4,5-B] PYRIDINE-7-CARBOXYLAMIDEAMIDE 704 | |
PL2155712T3 (pl) | 3-(imidazolilo)-pirazolo[3,4-b]pirydyny | |
IL229993A (en) | 8 - Alkoxy [1,2,4] triazolo [5,1 – c] pyrimidine– 2 | |
IL221479A0 (en) | Triazolo [4,5-b] pyridin derivatives | |
ZA201301313B (en) | Herbicidal isoxazolo[5,4-b]pyridines | |
EP2565194A4 (en) | Imidazo [1,2-A] pyridine | |
ZA201105257B (en) | 3-(3-pyrimidin-2-yl-benzyl)-[1,2,4]triazolo[4,3-b]pyrimidine derivatives | |
IL206666A0 (en) | N-PHENYLIMIDAZO[1,2-a]PYRIDINE-2- | |
BR112013013282A2 (pt) | compostos de oxazolo[5,4-b]piridin-5-ila |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA9A | Lapse of provisional patent protection due to relinquishment or protection considered relinquished |